|
|
|
|
Vol. 9, Issue 5, 393-394, May 1999
INSIGHT/OUTLOOK
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ARTICLE |
|---|
|
|
|---|
The basic mechanisms of mRNA translation are ubiquitous among all
organisms, in that the accurate decoding of triplet codon sequences
programs serial amide linkages of amino acid residues by ribosomal
complexes. In general, the fidelity of this process is dependent on both accurate recognition of mRNA codons by aminoacyl tRNAs and maintenance of the corresponding open reading frame. However,
in a growing number of cases, deviations from this triplet codon rule
are observed, indicating that the information content of an mRNA to
encode protein may extend beyond its primary structure. These cases,
collectively referred to as translational recoding (for review, see
Gesteland and Atkins 1996
), present exceptions to the venerable genetic
code and are typically subdivided among three primary mechanisms: (1)
frameshifting, in which translating ribosomes are induced to slide one
nucleotide forward or backward at a distinct point in the transcript,
with protein synthesis then continuing in the +1 or
1 reading
frame, respectively; (2) alternative codon usage, where stop codons are
not interpreted as sites of translational termination but, rather,
encode an amino acid residue; and (3) translational bypassing, where
the translational machinery traverses a gap in the mRNA coding sequence
yet yields a single polypeptide chain.
Programmed
1 ribosomal frameshift signals are among the most
extensively characterized of these translational recoding phenomena (for review, see Brierly 1995
; Dinman 1995
; Farabaugh 1996
). Although current examples are largely limited to viral systems, some bacterial
1 frameshifting events have also been documented (Blinkowa and Walker 1990
; Tsuchihashi and Brown 1992
; Chandler and Fayet 1993
; Engelberg-Kulka and Schoulaker-Schwarz 1994
). At present, no examples of eukaryotic mRNAs exhibiting
1 frameshift activity have been reported. However, a number of viruses infecting eukaryotic cells utilize programmed
1 ribosomal frameshifts, demonstrating that the
cis elements involved in the frameshifting process are
operational in eukaryotes. In viral systems, the efficiency of
frameshifting is an essential determinant of the stoichiometry of
synthesized viral protein products, which must be rigidly maintained
for efficient propagation of the virus (Brierly 1995
and references
therein; Dinman and Wickner 1995
).
In work presented in this issue, (Hammell et al. 1999
), a bioinformatic
approach was used to screen prokaryotic and eukaryotic DNA sequence
databases for potential
1 frameshift signals. Because of the
complexity of
1 frameshift sites and the sequence variability observed among these elements in nature, a multicomponent search algorithm was required to identify candidate sites from bulk database entries. This was made possible in part by the plethora of information available describing structural features of frameshift signals, much of
which is described in Hammell et al. (1999)
and elsewhere (Brierly
1995
; Chen et al. 1996
; Marczinke et al. 1998
). This strategy
represents a marked contrast to many examples of database searching,
which typically involve a single motif or are limited to primary
structure parameters (Fickett 1996
; Altschul et al. 1997
; Aravind and
Landsman 1998
; O'Neill 1998
).
Database searches using this compound algorithm for
1 frameshift
sites yielded a host of potential signals in all databases tested,
including eukaryotic sequences, with frequencies significantly higher
than found in random sequence populations. In a number of cases,
frameshift signals were conserved in homologous mRNAs from different
species. A convincing argument for the validity of these searches was
provided by the functional demonstration of
1 frameshifting
activity for two selected signals (from Saccharomyces cerevisiae
RAS1 and human CCR5 mRNAs) in a recombinant assay system. Furthermore, in four cases, potential
1 frameshift signals
colocalized to sites of mutation linked to heritable diseases in
humans, raising the possibility that
1 frameshift activity may be a
physiologically relevant component of regulated gene expression in
humans. Modifications of the parameters employed in this search
algorithm may yet reveal additional candidate frameshift signals, as
the potential for 3'-RNA pseudoknot formation was a constraint
placed upon their selection in this study. An RNA pseudoknot is not
requisite for
1 frameshifting at the gag-pol overlap of
HIV-1 (Jacks et al. 1988
), for example, which only contains a weak
3'-stem-loop structure in vivo (Parkin et al. 1992
).
The identification of functional
1 frameshift signals in
chromosomally encoded eukaryotic mRNAs raises several interesting questions for further investigation. First, it will be important to
determine if ribosomal frameshifting occurs in vivo in the context of
these transcripts. If so, what is the function of the frameshift event?
A ribosomal frameshift may serve to generate alternate protein
isoforms, with common amino-terminal sequences but distinct
carboxy-terminal regions. Protein products containing alternatively
framed moieties may present unique functional features or may be
subject to different modes of regulatory control. In other cases,
frameshifting events may have more direct regulatory roles. For
example, frameshifts could result in premature termination of protein
synthesis if the frameshift generates a stop codon in the
1 open
reading frame. In this case, the mRNA may be subject to accelerated
turnover by the nonsense-mediated mRNA decay pathway (for review, see
Maquat 1995
; Jacobson and Peltz 1996
; Ruiz-Echevarria et al. 1996
).
Another question regarding eukaryotic frameshifting events is whether
their efficiency may be regulated in response to signaling pathways or
other stimuli. This is particularly applicable in the context of
multicellular organisms, whose control of gene expression is often
subject to a host of endocrine and developmental effects.
If programmed
1 ribosomal frameshifting does not occur with
eukaryotic mRNAs, it is possible that flanking sequences may have
evolved to repress this activity. Alternatively, specific trans-acting factors may participate in the repression of
frameshifting events on eukaryotic transcripts. For example, the
MOF2/SUI1 gene product of S. cerevisiae functions as
an inhibitor of viral RNA frameshifting in infected yeast cells (Cui et
al. 1998
). This function is well conserved, as a yeast mof2
mutant can be rescued by the human homolog of SUI1. Maintenance of the
translational reading frame in yeast can also be influenced by 5S rRNA
(Dinman and Wickner 1995
), Upf1p (Cui et al. 1996
), and Upf3p
(Ruiz-Echevarria et al. 1998
). It is possible that a subset of such
factors may function to promote general translational fidelity but are
compromised during viral infection or some regulatory event.
Despite the identification of programmed
1 ribosomal frameshifting
activity associated with human mRNA sequences, the possibility of
developing antiviral therapeutic strategies targeting this mechanism
remains an intriguing possibility (Dinman et al. 1997
, 1998
; Hung et
al. 1998
). For example, compounds that modulate the stability of either
the downstream RNA structural motif or codon/anticodon interactions may
alter the efficiency of frameshifting events, leading to a change in
the ratio of frameshifted/nonshifted viral proteins. Because the
function of the RNA pseudoknot structure may involve retarding
translating ribosomes at the frameshift site (for review, see Brierly
1995
; Farabaugh 1996
), compounds modulating the kinetics of
translational elongation may similarly influence frameshit efficiency.
Obviously, the implications for modulation of host gene expression must
also be considered in the development of such therapies, but even
modest changes in viral frameshifting efficiency may be sufficient to
confer significant host benefit. This was demonstrated using LA virus
infection of yeast, where up- or down-regulation of frameshifting
efficiency by more than twofold prevented viral propagation (Dinman and
Wickner 1995
). Extrapolating to the possibility that alterations in
programmed
1 frameshifting may also contribute to human genetic
disorders, similar strategies aimed at modulating the frameshift
efficiencies of endogenous mRNAs may offer some therapeutic utility.
| |
FOOTNOTES |
|---|
1 Corresponding author.
E-MAIL gbrewer{at}wfubmc.edu; FAX (336) 716-9928.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Shigemoto, J. Brennan, E. Walls, C. J. Watson, D. Stott, P. W. J. Rigby, and A. D. Reith Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting Nucleic Acids Res., October 1, 2001; 29(19): 4079 - 4088. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Taylor, T. Triglia, J. Thompson, M. Sajid, R. Fowler, M. E. Wickham, A. F. Cowman, and A. A. Holder Plasmodium falciparum Homologue of the Genes for Plasmodium vivax and Plasmodium yoelii Adhesive Proteins, Which Is Transcribed but Not Translated Infect. Immun., June 1, 2001; 69(6): 3635 - 3645. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Kim, S. Maas, and A. Rich Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2 Nucleic Acids Res., March 1, 2001; 29(5): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Santagata, C. A. Gomez, C. Sobacchi, F. Bozzi, M. Abinun, S. Pasic, P. Cortes, P. Vezzoni, and A. Villa N-terminal RAG1 frameshift mutations in Omenn's syndrome: Internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains PNAS, December 19, 2000; 97(26): 14572 - 14577. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||